• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lipids and plasma fibrinogen: early and late composition of the atherosclerotic plaque.

作者信息

Smith E B

机构信息

Department of Clinical Biochemistry, University of Aberdeen, Scotland.

出版信息

Cardiologia. 1994 Dec;39(12 Suppl 1):169-72.

PMID:7634262
Abstract

Raised levels of plasma low density lipoprotein, lipoprotein (a), and fibrinogen have emerged as major risk factors for myocardial infarction and atherosclerosis. In this brief review some of their interactions with arterial intima are discussed. All the plasma macro-molecules appear to be present even in normal intima, and to cross the endothelium in healthy, young experimental animals by vesicular transport. The precursor of large fibrous plaques appears to be the gelatinous lesion, which is characterized by oedema, accumulation of large amounts of low density lipoproteins and fibrinogen in the expanded interstitial fluid space, deposition of fibrin, and smooth muscle cell proliferation. It is postulated that deposition of fibrin may be a key event, stimulating smooth muscle cell proliferation by providing a scaffold for migration, a source of fibrin degradation products which are mitogenic, and binding thrombin. Fibrin may also be a factor in lipid accumulation because it binds lipoprotein (a) with high affinity, and may also bind low density lipoprotein.

摘要

相似文献

1
Lipids and plasma fibrinogen: early and late composition of the atherosclerotic plaque.
Cardiologia. 1994 Dec;39(12 Suppl 1):169-72.
2
Fibrinogen and atherosclerosis.
Wien Klin Wochenschr. 1993;105(15):417-24.
3
Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.纤维蛋白原、纤维蛋白及纤维蛋白降解产物与动脉粥样硬化的关系
Clin Haematol. 1986 May;15(2):355-70.
4
Molecular interactions in human atherosclerotic plaques.人类动脉粥样硬化斑块中的分子相互作用。
Am J Pathol. 1977 Mar;86(3):665-74.
5
Fibrinogen, fibrin and the arterial wall.纤维蛋白原、纤维蛋白与动脉壁
Eur Heart J. 1995 Mar;16 Suppl A:11-4; discussion 14-5. doi: 10.1093/eurheartj/16.suppl_a.11.
6
Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products.
Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):489-93.
7
[The role of fibrinogen in the pathogenesis of artherosclerosis and the mechanisms of its action].[纤维蛋白原在动脉粥样硬化发病机制中的作用及其作用机制]
Sheng Li Ke Xue Jin Zhan. 1996 Jul;27(3):245-8.
8
Carotid atherosclerosis. Definition, pathogenesis, and clinical significance.
Neuroimaging Clin N Am. 1996 Nov;6(4):801-10.
9
Prothrombin-related antigens in human aortic intima.
Semin Thromb Hemost. 1996;22(4):347-50. doi: 10.1055/s-2007-999030.
10
Atherogenesis and inflammation.动脉粥样硬化形成与炎症
Eur Heart J. 1993 Dec;14 Suppl K:2-6.

引用本文的文献

1
Association between fibrinogen level and length of stay in patients with lower extremity atherosclerotic disease: a retrospective cohort study.纤维蛋白原水平与下肢动脉粥样硬化疾病患者住院时间的关系:一项回顾性队列研究。
Sci Rep. 2023 Jul 22;13(1):11872. doi: 10.1038/s41598-023-39219-x.
2
Lipids of Platelet-Rich Fibrin Reduce the Inflammatory Response in Mesenchymal Cells and Macrophages.富含血小板纤维蛋白的脂质可减少间充质细胞和巨噬细胞的炎症反应。
Cells. 2023 Feb 16;12(4):634. doi: 10.3390/cells12040634.
3
Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy.
抗 II 型胶原抗体和固有免疫在糖尿病视网膜病变发展和进展中的可能作用。
Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):387-403. doi: 10.1007/s00417-021-05342-6. Epub 2021 Aug 11.
4
Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia.血管内治疗的严重肢体缺血患者中,再狭窄与促血栓形成的血浆纤维蛋白凝块特征相关。
J Thromb Thrombolysis. 2019 May;47(4):540-549. doi: 10.1007/s11239-019-01826-9.